These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 32280378)

  • 1. Melatonin: new insights on its therapeutic properties in diabetic complications.
    Pourhanifeh MH; Hosseinzadeh A; Dehdashtian E; Hemati K; Mehrzadi S
    Diabetol Metab Syndr; 2020; 12():30. PubMed ID: 32280378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into the role of melatonin in diabetic cardiomyopathy.
    Huang K; Luo X; Zhong Y; Deng L; Feng J
    Pharmacol Res Perspect; 2022 Feb; 10(1):e00904. PubMed ID: 35005848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new prospective on the role of melatonin in diabetes and its complications.
    Mok JX; Ooi JH; Ng KY; Koh RY; Chye SM
    Horm Mol Biol Clin Investig; 2019 Nov; 40(1):. PubMed ID: 31693492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Melatonin on Diabetic Neuropathy and Retinopathy.
    Oliveira-Abreu K; Cipolla-Neto J; Leal-Cardoso JH
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus and melatonin: Where are we?
    Patel R; Parmar N; Pramanik Palit S; Rathwa N; Ramachandran AV; Begum R
    Biochimie; 2022 Nov; 202():2-14. PubMed ID: 35007648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress.
    Dehdashtian E; Mehrzadi S; Yousefi B; Hosseinzadeh A; Reiter RJ; Safa M; Ghaznavi H; Naseripour M
    Life Sci; 2018 Jan; 193():20-33. PubMed ID: 29203148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin synthesis impairment as a new deleterious outcome of diabetes-derived hyperglycemia.
    Amaral FG; Turati AO; Barone M; Scialfa JH; do Carmo Buonfiglio D; Peres R; Peliciari-Garcia RA; Afeche SC; Lima L; Scavone C; Bordin S; Reiter RJ; Menna-Barreto L; Cipolla-Neto J
    J Pineal Res; 2014 Aug; 57(1):67-79. PubMed ID: 24819547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Detailed Review of Molecular Pathways and Mechanisms Responsible for the Development and Aggravation of Neuropathy and Nephropathy in Diabetes.
    Chandra P; Sachan N; Saraswat N; Vyawahare N
    Curr Mol Pharmacol; 2024; 17(1):e280323215026. PubMed ID: 37018534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the effectiveness of melatonin in reducing the risk of foot ulcers in diabetic patients.
    Sajjadpour Z; Hoseini Tavassol Z; Aghaei Meybodi HR; Eskandarynasab M; Pejman Sani M; Hasani-Ranjbar S; Larijani B
    J Diabetes Metab Disord; 2023 Dec; 22(2):1073-1082. PubMed ID: 37975123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin ameliorates oxidative damage in hyperglycemia-induced liver injury.
    Korkmaz GG; Uzun H; Cakatay U; Aydin S
    Clin Invest Med; 2012 Dec; 35(6):E370-7. PubMed ID: 23217563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors.
    Busa P; Kuthati Y; Huang N; Wong CS
    Front Pharmacol; 2022; 13():864088. PubMed ID: 35496279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of melatonin on kidney injury in obese and diabetic conditions.
    Promsan S; Lungkaphin A
    Biofactors; 2020 Jul; 46(4):531-549. PubMed ID: 32449276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The research and development on the antioxidants in prevention of diabetic complications.
    Rahimi-Madiseh M; Malekpour-Tehrani A; Bahmani M; Rafieian-Kopaei M
    Asian Pac J Trop Med; 2016 Sep; 9(9):825-831. PubMed ID: 27633293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role and Therapeutic Potential of Melatonin in Degenerative Fundus Diseases: Diabetes Retinopathy and Age-Related Macular Degeneration.
    Ma C; Li H; Lu S; Li X
    Drug Des Devel Ther; 2024; 18():2329-2346. PubMed ID: 38911030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin ameliorates myocardial infarction in obese diabetic individuals: The possible involvement of macrophage apoptotic factors.
    Maity J; Dey T; Banerjee A; Chattopadhyay A; Das AR; Bandyopadhyay D
    J Pineal Res; 2023 Mar; 74(2):e12847. PubMed ID: 36456538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral supplementation with melatonin reduces oxidative damage and concentrations of inducible nitric oxide synthase, VEGF and matrix metalloproteinase 9 in the retina of rats with streptozotocin/nicotinamide induced pre-diabetes.
    Djordjevic B; Cvetkovic T; Stoimenov TJ; Despotovic M; Zivanovic S; Basic J; Veljkovic A; Velickov A; Kocic G; Pavlovic D; Sokolovic D
    Eur J Pharmacol; 2018 Aug; 833():290-297. PubMed ID: 29890158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential therapeutic value of melatonin in diabetic nephropathy: improvement beyond anti-oxidative stress.
    Guo C; He J; Deng X; Wang D; Yuan G
    Arch Physiol Biochem; 2023 Dec; 129(6):1250-1261. PubMed ID: 34048666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.
    Osawa T; Kato Y
    Ann N Y Acad Sci; 2005 Jun; 1043():440-51. PubMed ID: 16037265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Roles of Anti-Inflammatory Plant-Derived Bioactive Compounds Targeting Inflammation in Microvascular Complications of Diabetes.
    Kaabi YA
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin as a potential modulator of Nrf2.
    Ahmadi Z; Ashrafizadeh M
    Fundam Clin Pharmacol; 2020 Feb; 34(1):11-19. PubMed ID: 31283051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.